Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
18 oct. 2016 08h00 HE
|
Insmed Incorporated
Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE’s potential to achieve early and sustained negative sputum cultures BRIDGEWATER, N.J., Oct. 18, 2016 ...
Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor
05 oct. 2016 06h55 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed Appoints Roger Adsett as Chief Commercial Officer
27 sept. 2016 08h00 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed to Participate at September Investor Conferences
08 sept. 2016 08h00 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress
31 août 2016 08h00 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Reports Second Quarter 2016 Financial Results
04 août 2016 08h02 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe
08 juin 2016 16h30 HE
|
Insmed Incorporated
BRIDGEWATER, N.J., June 08, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today...
Insmed to Present at the Bank of America Global Healthcare Conference
09 mai 2016 08h00 HE
|
Insmed, Inc.
BRIDGEWATER, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Reports First Quarter 2016 Financial Results
05 mai 2016 08h03 HE
|
Insmed, Inc.
BRIDGEWATER, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...
Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting
03 mai 2016 08h00 HE
|
Insmed, Inc.
BRIDGEWATER, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported...